These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2636666)

  • 41. Effect of L-carnitine on ethanol and acetate plasma levels after oral administration of ethanol in humans.
    Adamo S; Siliprandi N; Dl Lisa F; Carrara M; Azzurro M; Sartori G; Vita G; Ghidini O
    Alcohol Clin Exp Res; 1988 Oct; 12(5):653-4. PubMed ID: 3067610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of acetate and bicarbonate dialysate on acyl carnitine in pyelonephritis.
    Jackson JM
    Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():786-8. PubMed ID: 10586325
    [No Abstract]   [Full Text] [Related]  

  • 43. L-Carnitine in dialysis, more than a commercial affair.
    Rodríguez-Benítez P; Pérez-García R; Arenas J; Valderrábano F
    Nephrol Dial Transplant; 2000 Sep; 15(9):1477-8. PubMed ID: 10978418
    [No Abstract]   [Full Text] [Related]  

  • 44. L-carnitine for anemia in hemodialysis patients: a last resort.
    Yee J
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1746-8. PubMed ID: 23085730
    [No Abstract]   [Full Text] [Related]  

  • 45. [Rapid gas chromatographic method for determination of acetate in human plasma and hemodialysis baths (author's transl)].
    Desch G; Descomps B
    Clin Chim Acta; 1977 Apr; 76(2):193-204. PubMed ID: 862194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacology of carnitine.
    Bahl JJ; Bressler R
    Annu Rev Pharmacol Toxicol; 1987; 27():257-77. PubMed ID: 3555318
    [No Abstract]   [Full Text] [Related]  

  • 47. Blood chemical continuous monitoring system for hemodialysis.
    Kabei N; Machiyama E; Yamada A; Kikuchi M; Sakurai Y
    Trans Am Soc Artif Intern Organs; 1978; 24():468-70. PubMed ID: 716041
    [No Abstract]   [Full Text] [Related]  

  • 48. Carnitine supplementation in uremia.
    Fürst P; Glöggler A; Rössle C
    Adv Exp Med Biol; 1989; 260():69-77. PubMed ID: 2696372
    [No Abstract]   [Full Text] [Related]  

  • 49. L-carnitine and peritoneal dialysis.
    Winchester JF
    Perit Dial Int; 2000; 20 Suppl 2():S150-3. PubMed ID: 10911661
    [No Abstract]   [Full Text] [Related]  

  • 50. Safety of oral carnitine in dialysis patients.
    Schreiber B
    Semin Dial; 2002; 15(1):71-2. PubMed ID: 11874598
    [No Abstract]   [Full Text] [Related]  

  • 51. A method of deliverying dialysate of constantly decreasing osmolality during dialysis.
    Chen WT; Ing TS; Daugirdas JT; Brescia DJ; Humayun H; Gandhi VC; Hano JE; Quon MJ
    Artif Organs; 1979 Nov; 3(4):377-9. PubMed ID: 533432
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of an acidic tripeptide in neurotoxic dialysate.
    Abiko T; Onodera I; Sekino H
    Chem Pharm Bull (Tokyo); 1980 May; 28(5):1629-33. PubMed ID: 7408052
    [No Abstract]   [Full Text] [Related]  

  • 53. [Acetate concentration in blood].
    Lentner C
    Dtsch Med Wochenschr; 1978 Aug; 103(32):1277. PubMed ID: 668583
    [No Abstract]   [Full Text] [Related]  

  • 54. [Acetate].
    Shimizu T
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():590-2. PubMed ID: 8753506
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acetate].
    Shimizu T
    Nihon Rinsho; 1999 Aug; 57 Suppl():650-2. PubMed ID: 10503526
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Kidney Int Suppl; 1989 Nov; 27():S247-55. PubMed ID: 2636666
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
    Glöggler A; Bulla M; Fürst P
    Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.